41 filings
8-K
DRMA
Dermata Therapeutics Inc
5 Jun 24
Other Events
9:02am
8-K
DRMA
Dermata Therapeutics Inc
24 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
DRMA
Dermata Therapeutics Inc
17 May 24
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
4:09pm
8-K
DRMA
Dermata Therapeutics Inc
15 May 24
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:06pm
8-K
DRMA
Dermata Therapeutics Inc
15 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
xkpf42
14 May 24
Material Modifications to Rights of Security Holders
9:16am
8-K
i6fx35fokyxrv tk1a6
7 May 24
Departure of Directors or Certain Officers
5:10pm
8-K
rbkdwcookzzvd
21 Mar 24
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results
4:05pm
8-K
qej27u6bv9w0bz jf6
12 Jan 24
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
d4cze
17 Nov 23
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
4:06pm
8-K
7b477
15 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:16pm
8-K
vipb4 88131o1
9 Nov 23
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
pkvncrcgyyz22w5yg5
10 Aug 23
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter
4:18pm
8-K
vcaktx48ko8 sz
3 Aug 23
Changes in Registrant's Certifying Accountant
4:31pm
8-K
2iky ieweg7873q
24 May 23
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
8-K
ye6vrw4cpm n4n5c4
11 May 23
Dermata Therapeutics Provides Corporate Update and Reports First Quarter
4:07pm
8-K
hd9kd7et pey
28 Mar 23
Other Events
4:06pm
8-K
11nwlelolgzh
20 Mar 23
Dermata Therapeutics Announces Pricing of $5.0 Million Public Offering
4:36pm
8-K
rqn4pc
13 Mar 23
Material Modifications to Rights of Security Holders
1:16pm
8-K
wt1phn ull
21 Feb 23
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Results
4:10pm